Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats-Reference-Cited by-同舟云学术

Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats

Published:2019-05 Issue: Volume:224 Page:177-186
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Chen Xingxing,Ge Wenhua,Dong Tiancheng,Hu Jie,Chen Lingzhi,Fan Xiaofang,Gong Yongsheng,Zhou Hao

Funder

National Natural Science Foundation of China

Wenzhou Science and Technology Bureau

Foundation for the Program of the Provincial Health Department of Zhejiang Province of China

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference37 articles.

1. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative;Ronco;Eur. Heart J.,2010

2. Effect of renal function on prognosis in chronic heart failure;Löffler;Am. J. Cardiol.,2015

3. Maternal and fetal adaptations during pregnancy: lessons in regulatory and integrative physiology;Granger;Am. J. Phys. Regul. Integr. Comp. Phys.,2002

4. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised placebo-controlled trial;Teerlink;Lancet,2013

5. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program: correlation with outcomes;Metra;J. Am. Coll. Cardiol.,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of extracorporeal shock wave on joint capsule fibrosis based on A2AR-Nrf2/HO-1 pathway in a rat extending knee immobilization model;Journal of Orthopaedic Surgery and Research;2023-12-06

2. Adenosine receptor signalling as a driver of pulmonary fibrosis;Pharmacology & Therapeutics;2023-09

3. Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research;Frontiers in Cardiovascular Medicine;2023-01-30

4. A2aR inhibits fibrosis and the EMT process in silicosis by regulating Wnt/β-catenin pathway;Ecotoxicology and Environmental Safety;2023-01

5. Corrigendum to “Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats” [Life Sci. 224 (2019) 177–186];Life Sciences;2022-06